Lionco Pharm Grp Co Ltd Total Liabilities
Lionco Pharm Grp Co Ltd total liabilities. Based on the latest financial reports, Lionco Pharm Grp Co Ltd (603669) has total liabilities worth CN¥482.64 Million CNY (≈ $70.62 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 603669 financial resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Lionco Pharm Grp Co Ltd (2011–2025)
Total liabilities of Lionco Pharm Grp Co Ltd from 2011 to 2025. This chart illustrates how Lionco Pharm Grp Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Lionco Pharm Grp Co Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.
Lionco Pharm Grp Co Ltd Competitors by Total Liabilities
The table below lists competitors of Lionco Pharm Grp Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
EXPLOS. PROD. CHIM.EO 31
F:9Z50
|
Germany | €311.65 Million |
|
Nuveen Dynamic Municipal Opportunities Fund
NYSE:NDMO
|
USA | $289.43 Million |
|
Sido Muncul PT
JK:SIDO
|
Indonesia | Rp265.52 Billion |
|
Sansec Technology Co. Ltd. A
SHG:688489
|
China | CN¥218.65 Million |
|
Hangzhou Zhengqiang Corporation Limited
SHE:301119
|
China | CN¥388.35 Million |
|
Rashtriya Chemicals and Fertilizers Limited
NSE:RCF
|
India | Rs-51.21 Billion |
|
Zaptec AS
OL:ZAP
|
Norway | Nkr425.90 Million |
|
Shenzhen Pacific Union Precision Manufacturing Co. Ltd. A
SHG:688210
|
China | CN¥1.84 Billion |
Liability Composition Analysis (2011–2025)
This chart breaks down Lionco Pharm Grp Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Lionco Pharm Grp Co Ltd total assets.
Liquidity & Leverage Metrics
Lionco Pharm Grp Co Ltd Total Liabilities Ratios Explained
Lionco Pharm Grp Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.22 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.75 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.43 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Lionco Pharm Grp Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Lionco Pharm Grp Co Ltd (2011–2025)
The table below shows the annual total liabilities of Lionco Pharm Grp Co Ltd from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥486.50 Million ≈ $71.19 Million |
+0.19% |
| 2024-12-31 | CN¥485.57 Million ≈ $71.05 Million |
-29.98% |
| 2023-12-31 | CN¥693.52 Million ≈ $101.48 Million |
-3.72% |
| 2022-12-31 | CN¥720.32 Million ≈ $105.41 Million |
-31.76% |
| 2021-12-31 | CN¥1.06 Billion ≈ $154.46 Million |
-14.62% |
| 2020-12-31 | CN¥1.24 Billion ≈ $180.91 Million |
+106.19% |
| 2019-12-31 | CN¥599.60 Million ≈ $87.74 Million |
-13.10% |
| 2018-12-31 | CN¥689.97 Million ≈ $100.96 Million |
+95.79% |
| 2017-12-31 | CN¥352.40 Million ≈ $51.57 Million |
+101.87% |
| 2016-12-31 | CN¥174.57 Million ≈ $25.54 Million |
-22.06% |
| 2015-12-31 | CN¥223.98 Million ≈ $32.78 Million |
+20.61% |
| 2014-12-31 | CN¥185.70 Million ≈ $27.17 Million |
-19.64% |
| 2013-12-31 | CN¥231.09 Million ≈ $33.82 Million |
+79.61% |
| 2012-12-31 | CN¥128.67 Million ≈ $18.83 Million |
+11.08% |
| 2011-12-31 | CN¥115.83 Million ≈ $16.95 Million |
-- |
About Lionco Pharm Grp Co Ltd
Lionco Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products and medical services in China. It offers chemical and prescription drugs for nutrition, antimicrobial, antiviral, digestive, cardiovascular, cerebrovascular, detoxification, anti-tumor, anti-infective drugs, and other applications. Lionco Phar… Read more